Latest News

AACR 2013 Multidisciplinary Cancer Teams Lack Information on Patients' Comborbidity

Multidisciplinary Cancer Teams Lack Information on Patients' Comborbidity

Multidisciplinary cancer team meetings need to systematically consider treatment of patients with comorbidity.

General Oncology News Radiation Therapists Face More Stressors Compared to Oncology Nurses

Radiation Therapists Face More Stressors Compared to Oncology Nurses

Radiation therapists also have high coping strategy frequency; no difference in anxiety, depression, burnout, well-being compared to oncology nurses.

General Oncology News Data Collection Improves Patient Outcomes in Hospice, Palliative Care

Data Collection Improves Patient Outcomes in Hospice, Palliative Care

Routine data collection and feedback at point-of-care improves most patient outcomes in hospice and palliative care.

General Oncology News Therapy Dogs May Help Patients with Cancer Persevere

Therapy Dogs May Help Patients with Cancer Persevere

People undergoing chemotherapy and radiation for cancer may get an emotional lift from dogs.

General Oncology News Physicians Face Obstacles in Making Cancer Referrals

Physicians Face Obstacles in Making Cancer Referrals

Many physicians report encountering barriers when referring cancer patients to specialty care.

General Oncology News Cancer Pain Drug Sativex Fails to Meet Primary Endpoint

Cancer Pain Drug Sativex Fails to Meet Primary Endpoint

Sativex did not meet its primary endpoint in demonstrating statistically significant difference from placebo for patients with advanced cancer.

General Oncology News Fibrates Prevent Paclitaxel- and Carboplatin-Induced Vascular Endothelial Dysfunction

Fibrates Prevent Paclitaxel- and Carboplatin-Induced Vascular Endothelial Dysfunction

Paclitaxel and carboplatin (TCchem) are chemotherapy agents associated with vascular toxicities caused by unclear mechanisms.

General Oncology News Safe Doses of Olaparib Plus Gemcitabine for Advanced Solid Tumors Determined

Safe Doses of Olaparib Plus Gemcitabine for Advanced Solid Tumors Determined

Intermittent dosing of olaparib plus gemcitabine is safe for the treatment of patients with advanced solid tumors.

General Oncology News Pyridoxine Not Effective for Prevention of Chemotherapy-Induced Hand-Foot Syndrome

Pyridoxine Not Effective for Prevention of Chemotherapy-Induced Hand-Foot Syndrome

No clinical evidence to support the use of pyridoxine (vitamin B6) supplementation for the prevention of hand-foot syndrome.

General Oncology News Diet Advice for Cancer Prevention: More Veggies, Less Alcohol

Diet Advice for Cancer Prevention: More Veggies, Less Alcohol

Eating a plant-based diet and limiting alcohol intake may help lower the risk for obesity-related cancers.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs